This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
Organizer(s): Cherié L. Butts, Amy S. Rosenberg, Amy D. Klion and Sachdev S. Sidhu
Date: January 22 - 26, 2017
Location: Snowbird Resort, Snowbird, UT, USA
Sponsored by Genmab A/S, ImmunoGen, Inc., Merck & Co., Inc., Mersana Therapeutics, Pfizer Inc. and Roche
Summary of Meeting:
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Scholarship Deadline: September 21 2016
Discounted Abstract Deadline: September 21 2016
Abstract Deadline: October 20 2016
Discounted Registration Deadline: November 21 2016
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Genmab A/SImmunoGen, Inc.Merck & Co., Inc.Mersana TherapeuticsPfizer Inc.Roche
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Amgen Inc.



Codiak Biosciences

EpiVax, Inc.

Regeneron Pharmaceuticals, Inc.

Thermo Fisher Scientific Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI126942-01
Funding for this conference was made possible (in part) by 1R13AI126942-01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found